Ishares Msci Brazil ETF vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Ishares Msci Brazil ETF trades at $42.86 (market cap $10.93B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Ishares Msci Brazil ETF is far larger — about 6.4× Nuvation Bio Inc. Class A Common Stock's market cap, and Ishares Msci Brazil ETF is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Brazil ETF for 50 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| EWZ | NUVB | |
|---|---|---|
Market Cap | $10.93B | $1.71B |
Volume | 45,143,031 | 5,448,712 |
Sector | Broad Market / Factor | Health |
52-Week High | $43.00 | $9.54 |
52-Week Low | $28.79 | $3.41 |
Typical Hold Time | 50 Days | 0 Days |
Enterprise Value | — | $1.30B |
Signals from Pluang's Aura AI — not financial advice
EWZ, the iShares MSCI Brazil ETF, trades at $42.37, down 1.47% today. The technical outlook is bullish based on moving averages but shows overbought signals with RSI readings above 70. Recent news highlights significant investor focus on Brazil's upcoming October election, with unusual options activity and institutional positioning indicating market anticipation of policy impacts.
The ETF offers diversification from U.S. markets with exposure to Brazilian commodities and financials. Key risks include election volatility and U.S. trade tariffs. Institutional buying and analyst views suggest cautious optimism, but high RSI levels warrant attention for near-term price pressure.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →